Clinics on Cloud spent eight years building Health ATMs - self-service kiosks that run preventive checkups like blood pressure, ECG, and basic blood work - before it raised a single rupee from an institutional investor. This week, the Pune-based company closed a Rs 120 crore Series A at a Rs 600 crore valuation, led by Dubai-based healthcare investment platform Model42, to fund expansion into the UAE, Africa, Southeast Asia, and the US. The company says it already has more than 3,500 installations and 12 million screenings across eight countries, built entirely on its own money.
The funding is the less interesting part of this story. The product category is the part worth sitting with.
The trust problem no hospital has to solve
A hospital’s trust is inherited. A patient walking into a building with doctors, nurses, and a reception desk is borrowing decades of institutional credibility the moment they walk in, even from a hospital they’ve never visited before. A Health ATM has none of that to lean on. It is a machine, often standing alone in a mall corridor or a workplace lobby, asking a stranger to let it near their body with no human in the loop to vouch for the result. That is a fundamentally harder trust problem than the one most consumer startups solve, because the thing being asked for isn’t a purchase decision. It’s physical consent, from someone who has no precedent for giving it to a machine.
Why manufacturing it themselves was the actual strategy
Most hardware-adjacent startups outsource manufacturing early to move faster. Clinics on Cloud runs its own facility at Chakan MIDC near Pune, and that choice looks less like a cost decision and more like a trust one. A company selling an unattended device that touches a stranger’s vitals cannot afford the version of the story where a third-party vendor’s build quality becomes the reason a reading was wrong. Owning the factory means owning the failure mode too, which is the only way to credibly promise a regulator, a mall landlord, or a nervous first-time user that the machine is accountable to someone.
What eight bootstrapped years actually bought
The founders, Abhay and Manashrri Agarwal, didn’t spend eight years avoiding seed rounds because nobody would write the cheque. They spent them building the one asset that doesn’t show up on a pitch deck line item: a machine people already trust enough to use without being told to, at scale, before an investor ever had to take that leap of faith on their behalf. The Rs 120 crore didn’t buy the first version of that trust. It bought the right to multiply a version that already existed, 12 million screenings deep, across markets where nobody has used a Health ATM before and the trust problem starts from zero all over again.
That’s the harder export than the hardware. The UAE-led expansion Model42 is funding will test whether trust built kiosk by kiosk in Indian malls travels to a market that has never seen the machine, or whether it has to be built from scratch again, country by country, the same slow way it was built the first time.